Positive Media Coverage Somewhat Unlikely to Affect Quorum Health (QHC) Stock Price

News articles about Quorum Health (NYSE:QHC) have been trending positive on Sunday, Accern reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Quorum Health earned a news impact score of 0.35 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.6562023266599 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Shares of QHC opened at $9.80 on Friday. The company has a debt-to-equity ratio of 10.69, a current ratio of 1.62 and a quick ratio of 1.47. The company has a market cap of $296.91, a price-to-earnings ratio of -7.54 and a beta of 1.61. Quorum Health has a 52 week low of $2.54 and a 52 week high of $9.95.

How to Become a New Pot Stock Millionaire

Quorum Health (NYSE:QHC) last issued its quarterly earnings data on Thursday, March 15th. The company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.02. The firm had revenue of $515.10 million during the quarter, compared to analyst estimates of $502.75 million. Quorum Health had a negative return on equity of 34.01% and a negative net margin of 5.51%. The company’s revenue for the quarter was up .0% on a year-over-year basis. During the same period in the previous year, the company posted ($1.02) EPS. analysts expect that Quorum Health will post -0.77 EPS for the current year.

A number of research analysts recently weighed in on the company. ValuEngine raised Quorum Health from a “sell” rating to a “hold” rating in a research note on Monday, April 2nd. Zacks Investment Research downgraded Quorum Health from a “hold” rating to a “sell” rating in a research note on Tuesday, March 20th. Finally, Morgan Stanley raised Quorum Health from an “underweight” rating to an “equal weight” rating and set a $3.00 price target on the stock in a research note on Wednesday, December 20th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. The company currently has an average rating of “Hold” and an average price target of $4.05.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3341039/positive-media-coverage-somewhat-unlikely-to-affect-quorum-health-qhc-stock-price.html.

About Quorum Health

Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. Its general hospital and outpatient healthcare services include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services.

Insider Buying and Selling by Quarter for Quorum Health (NYSE:QHC)

Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Capital One Financial Weighs in on Cousins Properties’ Q3 2018 Earnings
Capital One Financial Weighs in on Cousins Properties’ Q3 2018 Earnings
Royal Gold  Forecasted to Post Q3 2018 Earnings of $0.42 Per Share
Royal Gold Forecasted to Post Q3 2018 Earnings of $0.42 Per Share
Campbell Soup  Forecasted to Post Q3 2018 Earnings of $0.60 Per Share
Campbell Soup Forecasted to Post Q3 2018 Earnings of $0.60 Per Share
Infineon Technologies  PT Set at €28.00 by Goldman Sachs
Infineon Technologies PT Set at €28.00 by Goldman Sachs
Hauck & Aufhaeuser Reiterates €16.50 Price Target for Hamburger Hafen und Logistik
Hauck & Aufhaeuser Reiterates €16.50 Price Target for Hamburger Hafen und Logistik
Drägerwerk  Earns “Neutral” Rating from Deutsche Bank
Drägerwerk Earns “Neutral” Rating from Deutsche Bank


Leave a Reply

© 2006-2018 Ticker Report. Google+.